InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Scholtes Bret, Chairman & CEO. Insider active across 1 companies, notably Guardion Health Sciences, Inc.. Aggregated, 4 filings have been logged. Total volume traded: €10k. The latest transaction was disclosed on 6 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€21,35837,175 shares@ €0.574569.0% of flow
Common Stock
SEC:0001493152-22-016968:0·
152,671 shares
Common Stock
SEC:0001493152-22-005971:0·
€4,7944,500 shares@ €1.0654100.0% of flow
Common stock
SEC:0001493152-21-021791·
Ideal exit: 27 May 2022 (T+270)
€4,7944,500 shares@ €1.065415.5% of flow
Common stock
SEC:0001493152-21-021791:0·
Ideal exit: 27 May 2022 (T+270)
4 of 4 declarations
About Scholtes Bret
Bret Scholtes is the CEO and President of Guardion Health Sciences, Inc. As CEO, he is responsible for the strategic direction of the company, overseeing operations and growth initiatives. His leadership is essential for the organization's success.
